Description

Equipoise (EQ) Description:

Equipoise, also known as Boldenone Undecylenate (or Equipoise/EQ), is a popular steroid compound used by humans that are actually classified as a veterinary-grade anabolic-androgenic steroid (AAS) that is primarily still used for horses (hence the equestrian-related name). It is nearly identical to testosterone structurally but is commonly and falsely assumed to be similar in nature to Decagen (Nandrolone Decanoate). Decagen is a progestin drug better suited as a bulking steroid, whereas Equigen has no progestin qualities, so can be used to both bulk and cut due to it being roughly 50% less estrogenic than testosterone. Expect an increase in appetite, endurance, muscle mass, and more with Equigen.

Effects of Equipoise:

The effects of Equipoise are fairly straightforward. This is a generally well-tolerated anabolic steroid that presents notable anabolic activity in most users in a clean and even fashion. Outside of performance enhancement use, Boldenone did enjoy some success as a human grade steroid for a time.

Equipoise Benefits:

• Moderate muscle mass gainer
• Increased endurance
• Increased strength
• Helps preserve lean muscle tissue while in a calorie deficit
• Increased appetite
• Improved recovery from training
• Boosts protein synthesis
• Increased ability to burn body fat
• Low estrogenic side effects

Terminal Half-life:

• 14 days 

Possible Dosage & Cycle Length:

• Men @ 150-600 mg/week
• Women @ 50-100 mg/week
• 8-12 weeks

Equipoise Administration:

Standard Equipoise doses will normally fall in the 200-400mg per week range. Most men will find 400mg to be very well-tolerated and generally the minimal amount of EQ they’ll want to use. Many will also find 600mg per week to be extremely well-tolerated with side effects being extremely easy to control. However, such doses will increase estrogenic potential. Due to the long activity of the steroid, most men could easily get by with one injection per week, but splitting the weekly dose into 2-3 smaller injections will cut down on total injection volume. Further, some have reported side effects are even easier to control with a smaller more frequent injection schedule despite an extremely long half-life.